P/F Bakkafrost (LON:0MQ2)
488.04
-5.23 (-1.06%)
At close: Dec 12, 2025
P/F Bakkafrost Revenue
P/F Bakkafrost had revenue of 1.69B DKK in the quarter ending September 30, 2025, a decrease of -2.90%. This brings the company's revenue in the last twelve months to 6.48B, down -14.37% year-over-year. In the year 2024, P/F Bakkafrost had annual revenue of 7.33B with 2.70% growth.
Revenue (ttm)
6.48B DKK
Revenue Growth
-14.37%
P/S Ratio
2.80
Revenue / Employee
3.77M DKK
Employees
1,720
Market Cap
2.13B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.33B | 192.83M | 2.70% |
| Dec 31, 2023 | 7.14B | 10.88M | 0.15% |
| Dec 31, 2022 | 7.13B | 1.58B | 28.38% |
| Dec 31, 2021 | 5.55B | 901.96M | 19.39% |
| Dec 31, 2020 | 4.65B | 140.79M | 3.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |